{"title":"Maternal septic shock due to Acinetobacter lwoffii infection:a case report.","authors":"Hirotaka Isogami, Misa Sugeno, Karin Imaizumi, Toma Fukuda, Norihito Kamo, Shun Yasuda, Akiko Yamaguchi, Keiya Fujimori","doi":"10.5387/fms.2022-43","DOIUrl":"10.5387/fms.2022-43","url":null,"abstract":"<p><p>The incidence of Acinetobacter infections has increased in recent years. Acinetobacter infections are resistant to most antibiotics and can be found in hospitalized patients. Pregnancies complicated by severe sepsis or septic shock are associated with a higher rate of preterm labor and delivery, fetal infection, and operative delivery. This case report describes septic shock due to Acinetobacter lwoffii infection in the 31st week of gestation. A 47-year-old woman, with a gestation of 31 weeks and one day, presented with a fever, and signs of bacterial infection on laboratory tests. Although the patient was started on tazobactam/piperacillin, she went into septic shock, and was transferred to our hospital. Cesarean section was performed at a gestation of 31 weeks and 4 days because of severe maternal pneumonia and non-reassuring fetal status. A. lwoffii was detected in blood cultures collected at the previous hospital, and susceptibility to piperacillin and meropenem to A. lwoffii was confirmed. The pneumonia responded to antibiotic treatment and there were no findings of infection in the neonate. Maternal sepsis is an infrequent but important complication, causing significant maternal and fetal morbidity and fetal and neonatal mortality; therefore, early antibiotic therapy is required to improve the clinical outcome.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":" ","pages":"191-196"},"PeriodicalIF":0.8,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41177243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prediction of the prognosis of somatoform disorders using the Minnesota Multiphasic Personality Inventory.","authors":"Akiko Sato, Shuntaro Itagaki, Takatomo Matsumto, Yoko Ise, Shunya Yokokura, Tomohiro Wada, Kaoru Hayashi, Takeyasu Kakamu, Tetsuhito Fukushima, Takuya Nikaido, Shinichi Konno, Hirooki Yabe","doi":"10.5387/fms.2022-04","DOIUrl":"https://doi.org/10.5387/fms.2022-04","url":null,"abstract":"<p><strong>Background: </strong>Somatoform disorders are frequently resistant to treatment. This study aimed to determine the utility of the Minnesota Multifaceted Personality Inventory (MMPI) in predicting the prognosis of somatoform disorders.</p><p><strong>Methods: </strong>Overall, 125 patients diagnosed with somatoform disorders between January 1, 2013 and December 31, 2017 in the psychiatric department of Fukushima Medical University Hospital were included. Patients with positive outcomes were identified based on a subjective estimation regarding (1) pain and (2) social functions, including activities of daily living. They were divided into the improved group (IG) and the non-improved group (NIG). Each factor was then descriptively compared between the two groups, and the sensitivity and specificity were determined.</p><p><strong>Results: </strong>The NIG had significantly higher scores but only on the Hy scale. Thus, the optimal Hy scale cutoff score was calculated. The cutoff point was 73.5, with a sensitivity of 55.7% and a specificity of 71.7%.</p><p><strong>Conclusion: </strong>An MMPI Hy scale score higher than a cutoff value of 73.5 predicts a poor response to conventional supportive psychotherapy or drug therapy in patients with somatoform disorders. This cutoff point may be used as an important index for selecting treatment for somatoform disorders.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"105-113"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/8c/2185-4610-69-105.PMC10480515.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10175576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A muscle-preserving, spinous process-splitting approach for ossification of the ligamentum flavum in the thoracic spine in professional athletes: a report of three cases.","authors":"Kinshi Kato, Shoji Yabuki, Koji Otani, Takuya Nikaido, Kenichi Otoshi, Kazuyuki Watanabe, Hiroshi Kobayashi, Shin-Ichi Konno","doi":"10.5387/fms.2022-32","DOIUrl":"https://doi.org/10.5387/fms.2022-32","url":null,"abstract":"<p><p>A muscle-preserving, spinous process-splitting approach may be a less invasive approach to conventional laminectomy in patients with thoracic ossification of the ligamentum flavum. Few reports have discussed the usefulness of this procedure for thoracic lesions in professional athletes who need highly active thoracic spinal function after surgery. The treatment of thoracic ossification of the ligamentum flavum using a spinous process-splitting approach in 3 professional athletes is presented. In all three cases the patients could return to play within 3 months after surgery without complications, and in two of the cases, there was no spinal deformity or local recurrence of ossification of the ligamentum flavum at the final follow-up at least 8 years after surgery. The spinous process-splitting approach could be a safe procedure for multi-level and all other forms of ossification of the ligamentum flavum and is less invasive to the paraspinal muscles, relieves back symptoms, and restores function for athletes.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"143-150"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/56/2185-4610-69-143.PMC10480514.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10232372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect of rehabilitation in patients undergoing hematopoietic stem cell transplantation.","authors":"Takahiro Takekiyo, Shinichiro Morishita","doi":"10.5387/fms.2022-33","DOIUrl":"https://doi.org/10.5387/fms.2022-33","url":null,"abstract":"<p><p>Patients undergoing hematopoietic stem cell transplantation (HSCT) tend to experience decline in physical function, mental function, and quality of life (QOL) after HSCT due to low activity caused by adverse reactions to chemotherapy used in pre-transplantation treatment and post-transplant complications. Rehabilitation for HSCT patients is effective in preventing decline in physical function, reducing fatigue, and improving QOL. A combination of aerobic exercise and strength training is recommended for exercise therapy. Risk management is also important in the implementation of exercise therapy, and the exercise intensity should be determined according to the presence of anemia, low platelet counts, or post-transplant complications. On the other hand, post-transplant complications can decrease the patient's motivation and daily activity level. A multidisciplinary approach, which includes physicians and nurses, is important to achieve early discharge from the hospital and as quick a return to society as possible.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"73-83"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/03/2185-4610-69-073.PMC10480509.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10167366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk factors for anemia of prematurity among 30-35-week preterm infants.","authors":"Hiroki Kitaoka, Yoshihiko Shitara, Kohei Kashima, Shingo Ochiai, Hayato Chikai, Keiko Watanabe, Hiroto Ida, Tadayuki Kumagai, Naoto Takahashi","doi":"10.5387/fms.2022-21","DOIUrl":"10.5387/fms.2022-21","url":null,"abstract":"<p><strong>Background: </strong>The risk factors for anemia of prematurity (AOP) among late preterm infants are unelucidated. We identified risk factors for declining hemoglobin (Hb) concentration and triggering factors for AOP treatment in infants born at 30-35 gestational weeks.</p><p><strong>Methods: </strong>From 2012 to 2020, we conducted a single-center retrospective study of infants born at 30-35 weeks of gestation without congenital anomalies or severe hemorrhage. The primary outcome was AOP development, defined by initiation of treatments including red blood cell transfusion, subcutaneous injections of erythropoietin, and iron supplementation. A multivariable logistic regression model was used to investigate potential risk factors for AOP.</p><p><strong>Results: </strong>A total of 358 infants were included. Lower gestational age (odds ratio, 0.19; 95% confidence interval 0.11-0.32), small for gestational age (SGA; 7.17, 2.15-23.9), low maternal Hb level before birth (0.66, 0.49-0.87), low Hb at birth (0.71, 0.57-0.89), and multiple large blood samplings (1.79; 1.40-2.29) showed significantly higher odds for AOP development.</p><p><strong>Conclusions: </strong>Gestational age, SGA, low maternal Hb before birth, Hb at birth, and high number of large blood samplings were positively associated with AOP development in infants born at 30-35 gestational weeks.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"115-123"},"PeriodicalIF":0.7,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d6/cd/2185-4610-69-115.PMC10480510.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10167368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Staged hybrid repair for a patient with chronic type B aortic dissection.","authors":"Yuki Seto, Hitoshi Yokoyama, Shinya Takase, Tsuyoshi Fujimiya, Hiroharu Shinjo, Keiichi Ishida","doi":"10.5387/fms.2022-24","DOIUrl":"https://doi.org/10.5387/fms.2022-24","url":null,"abstract":"<p><p>Vascular prosthesis replacement and thoracic endovascular repair (TEVAR) are used to treat patients with enlarged chronic type B aortic dissection. A case in which thrombosis of the false lumen was achieved by the staged combination of these two methods is presented. A 41-year-old woman with a thoracoabdominal aortic aneurysm (maximum short diameter 44 mm) identified 5 years earlier was being monitored as an outpatient in our department when she presented with back pain. Computed tomography (CT) showed acute type B aortic dissection (DeBakey type IIIa), which was managed conservatively. When CT showed an aortic dissection with a patent false lumen immediately below the left subclavian artery bifurcation, one-debranching TEVAR was performed to close the entry, along with right axillary artery to left axillary artery bypass surgery. Outpatient CT at 3 months postoperatively showed rapid enlargement in the vicinity of the celiac artery. Thoracoabdominal aortic replacement to prevent rupture was performed, and the patient was then monitored as an outpatient. CT at age 43 years showed enlargement of the residual false lumen. Additional TEVAR was successfully performed. Thus, three-stage treatment was conducted to enlarge the residual false lumen, causing successful thrombosis of the false lumen.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"151-155"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/09/2185-4610-69-151.PMC10480512.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10175602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of general practice / family medicine training on Japanese junior residents:a descriptive study.","authors":"Koki Nakamura, Satoshi Kanke, Atsushi Ishii, Fuyuto Mori, Goro Hoshi, Kanako Kanto, Yoshihiro Toyoda, Ryuki Kassai","doi":"10.5387/fms.2022-35","DOIUrl":"https://doi.org/10.5387/fms.2022-35","url":null,"abstract":"<p><strong>Background: </strong>Despite international recognition of the impact of general practice / family medicine training on postgraduate training outcomes, there have been few reports from Japan.</p><p><strong>Methods: </strong>Junior residents who participated in community medicine training for one month between 2019 and 2022 were enrolled in the study. The settings were five medical institutions (one hospital and four clinics) that had full-time family doctors. The junior residents were assigned to one of these institutions. The training content mainly consisted of general ambulatory care, home medical care, community-based care, and reflection. The junior residents evaluated themselves at the beginning and end of their training, and the family doctors evaluated the junior residents at the end. The evaluation items were 36 items in 10 areas, based on the objectives outlined in the Guidelines for Residency Training - 2020 Edition, and were rated on a 10-point Likert scale. In the statistical analysis, Wilcoxon signed rank test of two related groups was performed to analyze changes between pre and post self-evaluation, and the effect size r was calculated.</p><p><strong>Results: </strong>Ninety-one junior residents completed the study. Their self-evaluations showed statistically significant increases in all 36 items. The effect size was large in 33 items. The family doctors' evaluation was 8-9 points for all 36 items.</p><p><strong>Conclusion: </strong>General practice / family medicine training may greatly contribute to the acquisition of various required clinical abilities in postgraduate training even in Japan.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"133-141"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/b4/2185-4610-69-133.PMC10480516.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10175578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yukihiko Kawasaki, Yohei Kume, Atsushi Ono, Ryo Maeda, Hayato Go
{"title":"Differences in response to treatment in children with severe IgA nephropathy according to patient age.","authors":"Yukihiko Kawasaki, Yohei Kume, Atsushi Ono, Ryo Maeda, Hayato Go","doi":"10.5387/fms.2022-42","DOIUrl":"https://doi.org/10.5387/fms.2022-42","url":null,"abstract":"<p><strong>Aim: </strong>To clarify whether the response to treatment of IgA nephropathy (IgAN) differs depending on patient age, we examined the response to treatment according to age of onset in children with IgAN.</p><p><strong>Methods: </strong>We collected data for 44 children with severe IgAN. The children were retrospectively divided into three groups based on their age at disease onset. Group 1 consisted of 24 children under 11 years old, group 2 consisted of 9 children aged 12 to 13 years, and group 3 consisted of 11 children aged over 14 years old. The clinical features and prognosis were analyzed for each group.</p><p><strong>Results: </strong>The urinary protein excretion and serum IgA values in group 3 were higher than those in groups 1 and 2 at the most recent follow up, and histological findings showed that the MESTCG scores in group 3 were higher than those in group 1. Furthermore, the incidence of patients with persistent nephropathy or renal insufficiency in group 3 was higher than those in groups 1 and 2.</p><p><strong>Conclusions: </strong>Patients aged 14 years and older with IgAN may respond poorly to treatment compared with those younger than 14 years old. Therefore, care must be taken regarding response to treatment and relapse when treating older children.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"125-132"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/59/2185-4610-69-125.PMC10480517.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10167365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Current progress in genomics and targeted therapies for neurofibromatosis type 2.","authors":"Ryo Hiruta, Kiyoshi Saito, Mudathir Bakhit, Masazumi Fujii","doi":"10.5387/fms.2023-05","DOIUrl":"https://doi.org/10.5387/fms.2023-05","url":null,"abstract":"<p><p>Neurofibromatosis type 2 (NF2), a multiple neoplasia syndrome, is a manifestation of an impaired expression of the merlin protein, exerting inhibitory effects on cell proliferation signals due to abnormalities of the NF2 gene located on chromosome 22. About half of patients inherit a germline mutation from a parent, and nearly 60% of de novo NF2 patients are estimated to have somatic mosaicism. The development of technical methods to detect NF2 gene mutation, including targeted deep sequencing from multiple tissues, improved the diagnostic rate of mosaic NF2. With improved understanding of genetics and pathogenesis, the diagnostic criteria for NF2 were updated to assist in identifying and diagnosing NF2 at an earlier stage. The understanding of cell signaling pathways interacting with merlin has led to the development of molecular-targeted therapies. Currently, several translational studies are searching for possible therapeutic agents targeting VEGF or VEGF receptors. Bevacizumab, an anti-VEGF monoclonal antibody, is widely used in many clinical trials aiming for hearing improvement or tumor volume control. Currently, a randomized, double-masked trial to assess bevacizumab is underway. In this randomized control trial, 12 other Japanese institutions joined the principal investigators in the clinical trial originating at Fukushima Medical University. In this review, we will be discussing the latest research developments regarding NF2 pathophysiology, including molecular biology, diagnosis, and novel therapeutics.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"95-103"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/7d/2185-4610-69-095.PMC10480513.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10233443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer's disease.","authors":"Hiroshi Matsuda, Tensho Yamao","doi":"10.5387/fms.2023-08","DOIUrl":"https://doi.org/10.5387/fms.2023-08","url":null,"abstract":"<p><p>Alzheimer's disease (AD) is diagnosed by the presence of both amyloid β and tau proteins. Recent advances in molecular PET imaging have made it possible to assess the accumulation of these proteins in the living brain. PET ligands have been developed that bind to 3R/4R tau in AD, but not to 3R tau or 4R tau alone. Of the first-generation PET ligands, <sup>18</sup>F-flortaucipir has recently been approved by the Food and Drug Administration. Several second-generation PET probes with less off-target binding have been developed and are being applied clinically. Visual interpretation of tau PET should be based on neuropathological neurofibrillary tangle staging instead of a simple positive or negative classification. Four visual read classifications have been proposed: \"no uptake,\" \"medial temporal lobe (MTL) only,\" \"MTL AND,\" and \"outside MTL.\" As an adjunct to visual interpretation, quantitative analysis has been proposed using MRI-based native space FreeSurfer parcellations. The standardized uptake value ratio of the target area is measured using the cerebellar gray matter as a reference region. In the near future, the Centiloid scale of tau PET is expected to be used as a harmonized value for standardizing each analytical method or PET ligand used, similar to amyloid PET.</p>","PeriodicalId":44831,"journal":{"name":"Fukushima Journal of Medical Science","volume":"69 2","pages":"85-93"},"PeriodicalIF":0.8,"publicationDate":"2023-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/79/2185-4610-69-085.PMC10480511.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10530203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}